Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour

• Status: RECRUITING
• Trial end date: 2030-12-01

Summary

Addition of postoperative chemotherapy to prevent or delay recurrence in patients newly diagnosed with localized uterine leiomyosarcoma and who have undergone complete tumor surgery.

• Phase: PHASE2

Details

• Lead Sponsor: UNICANCER
• Collaborators: Institut Bergonié; Institut Claudius Regaud; Ligue contre le cancer, France; National Research Agency, France; Oncopole; PharmaMar; University Hospital, Marseille
• Treatments: Doxorubicin; Trabectedin